Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Childhood APL
NCT00866918Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Mar 2009
- Primary completion
- Jun 2015
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of arsenic trioxide in acute promyelocytic leukemia (APL), sponsored by Children's Oncology Group. Started Mar 2009; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT00866918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00866918.